• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evaluation of the utility of NMR structures determined from minimal NOE-based restraints for structure-based drug design, using MMP-1 as an example.

作者信息

Huang X, Moy F, Powers R

机构信息

Department of Biological Chemistry, Wyeth Research, 85 Bolton Street, Cambridge, Massachusetts 02140, USA.

出版信息

Biochemistry. 2000 Nov 7;39(44):13365-75. doi: 10.1021/bi001658s.

DOI:10.1021/bi001658s
PMID:11063573
Abstract

The application of deuterium labeling and residual dipolar coupling constants in combination with other structural information has demonstrated the potential for significantly expanding the range of viable protein targets for structural analysis by NMR. A previous study by Clore et al. [(1999) J. Am. Chem. Soc. 121, 6513-6514] demonstrated that a significant improvement in the overall protein structure occurs with the combination of residual dipolar coupling constants and minimal tertiary long-range distance restraints. The analysis of NMR protein structures determined with minimal structural information is extended with a particular interest in the utility of these structures for a structure-based drug design program. As an example, the catalytic fragment of human fibroblast collagenase (MMP-1) was used to follow the effect of minimal restraint sets on the protein structure and its utility in drug design with a particular interest in the effect on the active site conformation. An MMP-1 structure that was calculated with the maximal number of restraints attainable with the constraint of a deuterated protein was shown to be very similar to a high-quality MMP-1 structure that was calculated from a complete set of restraints. The superposition of the active site backbone atoms for the high-quality and minimal restraint MMP-1 structures yielded an rmsd of 0.68 A where the size and shape of the S1' pocket are nearly identical. Additionally, an MMP-1-CGS-27023A complex based on a minimal set of NOE-based restraints reliably reproduced the structure of the complex, establishing the usefulness of the structures for drug design.

摘要

相似文献

1
Evaluation of the utility of NMR structures determined from minimal NOE-based restraints for structure-based drug design, using MMP-1 as an example.
Biochemistry. 2000 Nov 7;39(44):13365-75. doi: 10.1021/bi001658s.
2
NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound.人成纤维细胞胶原酶催化片段与异羟肟酸化合物的磺酰胺衍生物复合后的核磁共振溶液结构。
Biochemistry. 1999 Jun 1;38(22):7085-96. doi: 10.1021/bi982576v.
3
High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.人胶原酶-3(基质金属蛋白酶-13)催化片段与异羟肟酸抑制剂复合物的高分辨率溶液结构。
J Mol Biol. 2000 Sep 22;302(3):671-89. doi: 10.1006/jmbi.2000.4082.
4
High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR.通过多维核磁共振确定的人成纤维细胞胶原酶无抑制剂催化片段的高分辨率溶液结构。
Biochemistry. 1998 Feb 10;37(6):1495-504. doi: 10.1021/bi972181w.
5
Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1.与一种强效非肽磺酰胺抑制剂复合的人胶原酶-3(基质金属蛋白酶-13)催化结构域的溶液结构:与基质溶解素-1和胶原酶-1的结合比较
J Mol Biol. 2000 Aug 11;301(2):513-24. doi: 10.1006/jmbi.2000.3988.
6
Impact of mobility on structure-based drug design for the MMPs.迁移率对基质金属蛋白酶基于结构的药物设计的影响。
J Am Chem Soc. 2002 Oct 30;124(43):12658-9. doi: 10.1021/ja027391x.
7
Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.与疏水抑制剂复合的人基质溶解素催化结构域的溶液结构
Protein Sci. 1995 Dec;4(12):2487-98. doi: 10.1002/pro.5560041205.
8
Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor.与异羟肟酸抑制剂复合的基质金属蛋白酶-2催化结构域的溶液结构和主链动力学
Biochim Biophys Acta. 2002 Jul 29;1598(1-2):10-23. doi: 10.1016/s0167-4838(02)00307-2.
9
Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent, nonpeptidic inhibitor.
Biochemistry. 1998 Oct 6;37(40):14048-56. doi: 10.1021/bi981328w.
10
Global folds of proteins with low densities of NOEs using residual dipolar couplings: application to the 370-residue maltodextrin-binding protein.利用剩余偶极耦合确定低核Overhauser效应密度蛋白质的全局折叠:应用于370个残基的麦芽糖糊精结合蛋白
J Mol Biol. 2000 Jun 30;300(1):197-212. doi: 10.1006/jmbi.2000.3842.

引用本文的文献

1
Modern Technologies of Solution Nuclear Magnetic Resonance Spectroscopy for Three-dimensional Structure Determination of Proteins Open Avenues for Life Scientists.用于蛋白质三维结构测定的溶液核磁共振光谱现代技术为生命科学家开辟了道路。
Comput Struct Biotechnol J. 2017 Apr 13;15:328-339. doi: 10.1016/j.csbj.2017.04.001. eCollection 2017.
2
Advances in Nuclear Magnetic Resonance for Drug Discovery.用于药物发现的核磁共振技术进展
Expert Opin Drug Discov. 2009 Oct 1;4(10):1077-1098. doi: 10.1517/17460440903232623.
3
Improvement of hydrogen bond geometry in protein NMR structures by residual dipolar couplings--an assessment of the interrelation of NMR restraints.
通过残余偶极耦合改善蛋白质核磁共振结构中的氢键几何结构——核磁共振约束相互关系的评估
J Biomol NMR. 2004 Jan;28(1):31-41. doi: 10.1023/B:JNMR.0000012865.35872.cc.
4
Applications of NMR to structure-based drug design in structural genomics.核磁共振在结构基因组学中基于结构的药物设计中的应用。
J Struct Funct Genomics. 2002;2(2):113-23. doi: 10.1023/a:1020445506369.
5
Structure-independent cross-validation between residual dipolar couplings originating from internal and external orienting media.源自内部和外部定向介质的剩余偶极耦合之间的结构无关交叉验证。
J Biomol NMR. 2002 Apr;22(4):365-8. doi: 10.1023/a:1014980101965.
6
Structure refinement of flexible proteins using dipolar couplings: application to the protein p8MTCP1.利用偶极耦合对柔性蛋白质进行结构优化:应用于蛋白质p8MTCP1。
J Biomol NMR. 2002 Jan;22(1):47-56. doi: 10.1023/a:1013821123201.